The DOI matches its Crossref record; 209 of the 211 references it cites were found in a registry or an index.
Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is characterized by a progressive degeneration of upper and lower motor neurons, resulting in fatal paralysis due to denervation of the muscle. Due to genetic, pathological and symptomatic overlap, ALS is now considered a spectrum disease together with frontotemporal dementia (FTD), the second most common cause of dementia in individuals under the age of 65. Interestingly, in both diseases, there is a large prevalence of RNA binding proteins (RBPs) that are mutated and considered disease-causing, or whose dysfunction contribute to disease pathogenesis. The most common shared genetic mutation in ALS/FTD is a hexanucleuotide repeat expansion within intron 1 of C9ORF72 (C9). Three potentially overlapping, putative toxic mechanisms have been proposed: loss of function due to haploinsufficient expression of the C9ORF72 mRNA, gain of function of the repeat RNA aggregates, or RNA foci, and repeat-associated non-ATG-initiated translation (RAN) of the repeat RNA into toxic dipeptide repeats (DPRs). Regardless of the causative mechanism, disease symptoms are ultimately caused by a failure of neurotransmission in three regions: the brain, the spinal cord, and the neuromuscular junction. Here, we review C9 ALS/FTD-associated synaptic dysfunction and aberrant neuronal excitability in these three key regions, focusing on changes in morphology and synapse formation, excitability, and excitotoxicity in patients, animal models, and in vitro models. We compare these deficits to those seen in other forms of ALS and FTD in search of shared pathways, and discuss the potential targeting of synaptic dysfunctions for therapeutic intervention in ALS and FTD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The combination of NPTX2 (representing synaptic plasticity [35]), NfL (marker for overall neurodegeneration [60, 61]), and GFAP (depicting astrogliosis [62]) reflects the complexity of pathological mechanisms involved in neurodegenerative disorders and FTD in particular [63–66]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“…loss and dysfunction (i.e. synaptopathy) is believed to occur early in disease progression of cognitive disorders including Alzheimer’s disease (AD) (DeKosky and Scheff, 1990; Selkoe, 2002; Terry et al., 1991) and Frontotemporal Dementia (FTD) (Gong and Lippa, 2010; Petkau et al., 2012), and in…”
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
AMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Decoding ALS: from genes to mechanism
Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,120
Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate
Olney, J. (1969) · Science · doi:10.1126/science.164.3880.719 · Cited by 1,885
Transcranial magnetic stimulation and the human brain
Hallett, M. (2000) · Nature · doi:10.1038/35018000 · Cited by 1,603 · cited 2×
“Cortical hyperexcitability is measured with the use of transcranial magnetic stimulation (TMS; (Hallett, 2000)) and can be detected in both sporadic and familial ALS patients, including C9ORF72 patients, as well as some subsets of FTD patients, suggesting that divergent mechanistic pathways lead to…”
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
RNA editing in brain controls a determinant of ion flow in glutamate-gated channels
Sommer, B., Köhler, M., Sprengel, R., & Seeburg, P. H. (1991) · Cell · doi:10.1016/0092-8674(91)90568-j · Cited by 1,517
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Ca2 + Permeability of KA-AMPA—Gated Glutamate Receptor Channels Depends on Subunit Composition
Hollmann, M., Hartley, M., & Heinemann, S. F. (1991) · Science · doi:10.1126/science.1709304 · Cited by 1,450
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature reviews. Neuroscience · doi:10.1038/35097565 · Cited by 1,389
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248
Functions and Regulation of RNA Editing by ADAR Deaminases
Nishikura, K. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-105251 · Cited by 1,242
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,127
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., Steinwald, P., Daley, E. L., Miller, S. J., Cunningham, K. M., Vidensky, S., et al. (2015) · Nature · doi:10.1038/nature14973 · Cited by 982
Self-citationAMPARs and Synaptic Plasticity: The Last 25 Years
Huganir, R. L., & Nicoll, R. A. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.025 · Cited by 968
The ageing cortical synapse: hallmarks and implications for cognitive decline
Morrison, J. H., & Baxter, M. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3200 · Cited by 965
Stress granules as crucibles of ALS pathogenesis
Li, Y. R., King, O. D., Shorter, J., & Gitler, A. D. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201302044 · Cited by 948
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
Self-citationEvidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons
Wenthold, R., Petralia, R., Blahos J, II, & Niedzielski, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-01982.1996 · Cited by 850
GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport
Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., Lee, K.-H., Badders, N., Valentine, M., Miller, B. L., Wong, P. C., et al. (2015) · Nature · doi:10.1038/nature14974 · Cited by 841
Astrocytes from familial and sporadic ALS patients are toxic to motor neurons
Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., Song, S., Likhite, S., Murtha, M. J., Foust, K. D., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1957 · Cited by 782
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
Zu, T., Liu, Y., Báñez-Coronel, M., Reid, T. S., Pletniková, O., Lewis, J. M., Miller, T. M., Harms, M. B., Falchook, A. E., Subramony, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315438110 · Cited by 777
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O. C., Pietrzyk, J., et al. (2014) · Science · doi:10.1126/science.1256800 · Cited by 740
Lui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.-Y., Shang, Y., Oldham, M. C., Martens, L. H., Gao, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.001 · Cited by 729
Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons
Wainger, B. J., Kiskinis, E., Mellin, C., Wiskow, O., Han, S. S. W., Sandoe, J., Perez, N. P., Williams, L. A., Lee, S., Boulting, G. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.019 · Cited by 676
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations
Alami, N. H., Smith, R. B., Carrasco, M. A., Williams, L. A., Winborn, C. S., Han, S. S. W., Kiskinis, E., Winborn, B., Freibaum, B. D., Kanagaraj, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.018 · Cited by 660
Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells
Kwon, I., Xiang, S., Kato, M., Wu, L. C., Theodoropoulos, P., Wang, T., Kim, J., Yun, J., Xie, Y., & McKnight, S. L. (2014) · Science · doi:10.1126/science.1254917 · Cited by 656
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
Rothstein, J. D., Tsai, G. E., Kuncl, R. W., Clawson, L., Cornblath, D. R., Drachman, D. B., Pestronk, A., Stauch, B. L., & Coyle, J. T. (1990) · Annals of Neurology · doi:10.1002/ana.410280106 · Cited by 637
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes‐Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623
Jovičić, A., Mertens, J., Boeynaems, S., Bogaert, E., Chai, N., Yamada, S. B., Paul, J. W., Sun, S., Herdy, J. R., Bieri, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4085 · Cited by 598
Lagier‐Tourenne, C., Baughn, M. W., Rigo, F., Sun, S., Liu, P., Li, H., Jiang, J., Watt, A. T., Chun, S. J., Katz, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318835110 · Cited by 585
Imaging synaptic density in the living human brain
Finnema, S. J., Nabulsi, N. B., Eid, T., Detyniecki, K., Lin, S.-F., Chen, M.-K., Dhaher, R., Matuskey, D., Baum, E., Holden, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6667 · Cited by 575
C9orf72 is required for proper macrophage and microglial function in mice
O’Rourke, J. G., Bogdanik, L., Yáñez, A., Lall, D., Wolf, A. J., Muhammad, A. K. M. G., Ho, R., Carmona, S., Vit, J. P., Zarrow, J., et al. (2016) · Science · doi:10.1126/science.aaf1064 · Cited by 550
Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules
Bosco, D. A., Lemay, N., Ko, H. K., Zhou, H., Burke, C., Kwiatkowski, T. J., Sapp, P. C., McKenna-Yasek, D. M., Brown, R. H., & Hayward, L. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq335 · Cited by 537
RNA editing and death of motor neurons
Kawahara, Y., Ito, K., Sun, H. J., Aizawa, H., Kanazawa, I., & Kwak, S. (2004) · Nature · doi:10.1038/427801a · Cited by 536
Jiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536
Wen, X., Tan, W., Westergard, T., Krishnamurthy, K., Markandaiah, S. S., Shi, Y., Lin, S., Shneider, N. A., Monaghan, J., Pandey, U. B., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.12.010 · Cited by 533
Synaptic AMPA receptor composition in development, plasticity and disease
Henley, J. M., & Wilkinson, K. A. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.37 · Cited by 526
Bannwarth, S., Ait-El-Mkadem, S., Chaussenot, A., Genin, E. C., Lacas‐Gervais, S., Fragaki, K., Berg-Alonso, L., Kageyama, Y., Serre, V., Moore, D. G., et al. (2014) · Brain · doi:10.1093/brain/awu138 · Cited by 507
Lee, Y., Chen, H.-J., Peres, J., Gómez-Deza, J., Attig, J., Štalekar, M., Troakes, C., Nishimura, A. L., Scotter, E. L., Vance, C. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.049 · Cited by 487
Marchetto, M. C. N., Muotri, A. R., Mu, Y., Smith, A. M., Cezar, G. G., & Gage, F. H. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.001 · Cited by 475
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
Vucic, S., Nicholson, G. A., & Kiernan, M. C. (2008) · Brain · doi:10.1093/brain/awn071 · Cited by 460
Buchan, J. R. (2014) · RNA Biology · doi:10.4161/15476286.2014.972208 · Cited by 459
A developmentally regulated activity that unwinds RNA duplexes
BASS, B. (1987) · Cell · doi:10.1016/0092-8674(87)90239-x · Cited by 446
Danbolt, N. C., Storm‐Mathisen, J., & Kanner, B. I. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90316-t · Cited by 445
Kim, U., Wang, Y., Sanford, T., Zeng, Y., & Nishikura, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11457 · Cited by 442
Motor Neurons Are Selectively Vulnerable to AMPA/Kainate Receptor-Mediated InjuryIn Vitro
Carriedo, S. G., Yin, H. Z., & Weiss, J. H. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-13-04069.1996 · Cited by 440
Sellier, C., Campanari, M., Julie Corbier, C., Gaucherot, A., Kolb‐Cheynel, I., Oulad‐Abdelghani, M., Ruffenach, F., Page, A., Ciura, S., Kabashi, E., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593350 · Cited by 414
Bellingham, M. C. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00116.x · Cited by 388
C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD
Liu, Y., Pattamatta, A., Zu, T., Reid, T. S., Bardhi, O., Borchelt, D., Yachnis, A. T., & Ranum, L. P. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.005 · Cited by 368
Nonhoff, U., Ralser, M., Welzel, F., Piccini, I., Balzereit, D., Yaspo, M., Lehrach, H., & Krobitsch, S. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1120 · Cited by 357
Zhang, Y., Jansen‐West, K. R., Xu, Y.-F., Gendron, T. F., Bieniek, K. F., Lin, W.-L., Sasaguri, H., Caulfield, T. R., Hubbard, J., Daughrity, L. M., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1336-5 · Cited by 346
Raymond, L. A., André, V. M., Cepeda, C., Gladding, C. M., Milnerwood, A. J., & Levine, M. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.052 · Cited by 336
Ciura, S., Lattante, S., Le Ber, I., Latouche, M., Tostivint, H., Brice, A., & Kabashi, E. (2013) · Annals of Neurology · doi:10.1002/ana.23946 · Cited by 333
Almeida, S., Gascon, E., Tran, H., Chou, H. J., Gendron, T. F., DeGroot, S., Tapper, A. R., Sellier, C., Charlet-Berguerand, N., Karydas, A., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1149-y · Cited by 321
May, S., Hornburg, D., Schludi, M. H., Arzberger, T., Rentzsch, K., Schwenk, B. M., Grässer, F. A., Mori, K., Kremmer, E., Banzhaf‐Strathmann, J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1329-4 · Cited by 317
Devlin, A., Burr, K., Borooah, S., Foster, J. D., Cleary, E. M., Geti, I., Vallier, L., Shaw, C. E., Chandran, S., & Miles, G. B. (2015) · Nature Communications · doi:10.1038/ncomms6999 · Cited by 308
C 9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits
Koppers, M., Blokhuis, A. M., Westeneng, H., Terpstra, M. L., Zundel, C. A. C., de Sá, R. V., Schellevis, R. D., Waite, A. J., Blake, D. J., Veldink, J. H., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24453 · Cited by 301
C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD
O’Rourke, J. G., Bogdanik, L., Muhammad, A. K. M. G., Gendron, T. F., Kim, K. J., Austin, A., Cady, J., Liu, E. Y., Zarrow, J., Grant, S., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.027 · Cited by 298
Local RNA Translation at the Synapse and in Disease: Figure 1.
Liu‐Yesucevitz, L., Bassell, G. J., Gitler, A. D., Hart, A. C., Klann, E., Richter, J. D., Warren, S. T., & Wolozin, B. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4105-11.2011 · Cited by 296
RED2, a Brain-specific Member of the RNA-specific Adenosine Deaminase Family
Melcher, T., Maas, S., Herb, A., Sprengel, R., Higuchi, M., & Seeburg, P. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31795 · Cited by 295
Synaptic Dysfunction in Parkinson’s Disease
Picconi, B., Piccoli, G., & Calabresi, P. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_24 · Cited by 286
Calcium dysregulation in amyotrophic lateral sclerosis
Großkreutz, J., Bosch, L. V. D., & Keller, B. U. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.002 · Cited by 284
Kim, H. J., & Taylor, J. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.029 · Cited by 280
Peters, O. M., Cabrera, G. T., Tran, H., Gendron, T. F., McKeon, J. E., Metterville, J., Weiss, A., Wightman, N., Salameh, J. S., Kim, J., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.11.018 · Cited by 278
Seeburg, P. H., Higuchi, M., & Sprengel, R. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00062-3 · Cited by 270
D‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis
Sasabe, J., Chiba, T., Yamada, M., Okamoto, K., Nishimoto, I., Matsuoka, M., & Aiso, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601840 · Cited by 269
Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase
O’Connell, M. A., Krause, S., Higuchi, M., Hsuan, J. J., Totty, N. F., Jenny, A., & Keller, W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1389 · Cited by 268
Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase
Mitchell, J., Paul, P., Chen, H.-J., Morris, A. G., Payling, M., Falchi, M., Habgood, J., Panoutsou, S., Winkler, S., Tisato, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914128107 · Cited by 262
Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD
Boeynaems, S., Bogaert, E., Michiels, E., Gijselinck, I., Sieben, A., Jovičić, A., De Baets, G., Scheveneels, W., Steyaert, J., Cuijt, I., et al. (2016) · Scientific Reports · doi:10.1038/srep20877 · Cited by 262
The high affinity uptake system for excitatory amino acids in the brain
Danbolt, N. C. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90033-7 · Cited by 257
Dafinca, R., Scaber, J., Ababneh, N. A., Lalic, T., Weir, G. A., Christian, H., Vowles, J., Douglas, A. G. L., Fletcher-Jones, A., Browne, C., et al. (2016) · Stem Cells · doi:10.1002/stem.2388 · Cited by 243
Peng, P. L., Zhong, X., Tu, W., Soundarapandian, M. M., Molner, P., Zhu, D., Lau, L. W., Liu, S., Liu, F., & Lu, Y. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.025 · Cited by 234
Pathophysiological and diagnostic implications of cortical dysfunction in ALS
Geevasinga, N., Menon, P., Özdi̇nler, P. H., Kiernan, M. C., & Vucic, S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.140 · Cited by 231
The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain
Wright, A. L., & Vissel, B. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00034 · Cited by 229
Genetic mutations in RNA-binding proteins and their roles in ALS
Kapeli, K., Martinez, F. J., & Yeo, G. W.-M. (2017) · Human Genetics · doi:10.1007/s00439-017-1830-7 · Cited by 225
d -Amino acid oxidase controls motoneuron degeneration through d -serine
Sasabe, J., Miyoshi, Y., Suzuki, M., Mita, M., Konno, R., Matsuoka, M., Hamase, K., & Aiso, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114639109 · Cited by 224
Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis
Kwak, S., & Kawahara, Y. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0599-z · Cited by 215
Selvaraj, B. T., Livesey, M. R., Zhao, C., Gregory, J. M., James, O. T., Cleary, E. M., Chouhan, A. K., Gane, A. B., Perkins, E., Dando, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02729-0 · Cited by 214
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis
Miller, R. G., Moore, D. H., Gelinas, D. F., Dronsky, V., Mendoza, M., Barohn, R. J., Bryan, W. W., Ravits, J., Yuen, E., Neville, H. E., et al. (2001) · Neurology · doi:10.1212/wnl.56.7.843 · Cited by 212
Sanderson, J. L., Gorski, J. A., & Dell’Acqua, M. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.043 · Cited by 210
Tran, H., Almeida, S., Moore, J. E., Gendron, T. F., Chalasani, U., Lu, Y., Du, X., Nickerson, J. A., Petrucelli, L., Weng, Z., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.09.015 · Cited by 204
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
Cudkowicz, M., Shefner, J. M., Schoenfeld, D., Brown, R. H., Jr., Johnson, H., Qureshi, M., Jacobs, M., Rothstein, J. D., Appel, S. H., Pascuzzi, R. M., et al. (2003) · Neurology · doi:10.1212/wnl.61.4.456 · Cited by 203
Couratier, P., Sindou, P., Hugon, J., Couratier, P., Hugon, J., Vallat, J., & Dumas, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)92615-z · Cited by 189
Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons
Hideyama, T., Yamashita, T., Aizawa, H., Tsuji, S., Kakita, A., Takahashi, H., & Kwak, S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.033 · Cited by 189
Deletion of C9ORF72 Results in Motor Neuron Degeneration and Stress Sensitivity in C. elegans
Therrien, M., Rouleau, G. A., Dion, P. A., & Parker, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083450 · Cited by 183
Gascon, E., Lynch, K., Ruan, H., Almeida, S., Verheyden, J. M., Seeley, W. W., Dickson, D. W., Petrucelli, L., Sun, D., Jiao, J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3717 · Cited by 183
Hall, C. E., Yao, Z., Choi, M., Tyzack, G. E., Serio, A., Luisier, R., Harley, J., Preza, E., Arber, C., Crisp, S. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.024 · Cited by 179
Synaptic dysfunction in progranulin-deficient mice
Petkau, T. L., Neal, S. J., Milnerwood, A. J., Mew, A., Hill, A. M., Orban, P. C., Gregg, J., Lu, G., Feldman, H., Mackenzie, I. R., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.016 · Cited by 175
Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders
Zhang, W., Zhang, L., Liang, B., Schroeder, D. G., Zhang, Z., Cox, G. A., Li, Y., & Lin, D. (2016) · Nature Neuroscience · doi:10.1038/nn.4257 · Cited by 173
The origin of muscle fasciculations and cramps
Layzer, R. B. (1994) · Muscle & Nerve · doi:10.1002/mus.880171102 · Cited by 170
FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization
Udagawa, T., Fujioka, Y., Tanaka, M., Honda, D., Yokoi, S., Riku, Y., Ibi, D., Nagai, T., Yamada, K., Watanabe, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8098 · Cited by 167
Rocha, M. C., Pousinha, P. A., Correia, A. M., Sebastião, A. M., & Ribeiro, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073846 · Cited by 165
Synaptic dysfunction in Parkinson's disease
Bagetta, V., Ghiglieri, V., Sgobio, C., Calabresi, P., & Picconi, B. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380493 · Cited by 161
Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2
Hideyama, T., Yamashita, T., Suzuki, T., Tsuji, S., Higuchi, M., Seeburg, P. H., Takahashi, R., Misawa, H., & Kwak, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2021-10.2010 · Cited by 158
Activity-dependent FUS dysregulation disrupts synaptic homeostasis
Sephton, C. F., Tang, A. A., Kulkarni, A., West, J. D., Brooks, M., Stubblefield, J. J., Liu, Y., Zhang, M. Q., Green, C. B., Huber, K. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406162111 · Cited by 156
There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS
Gitler, A. D., & Tsuiji, H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.004 · Cited by 155
Xiao, S., MacNair, L., McGoldrick, P., McKeever, P. M., McLean, J. R., Zhang, M., Keith, J. L., Zinman, L. H., Rogaeva, E. A., & Robertson, J. (2015) · Annals of Neurology · doi:10.1002/ana.24469 · Cited by 154
Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes.
Keegan, L. P., Leroy, A., Sproul, D., & O’Connell, M. A. (2004) · Genome biology · doi:10.1186/gb-2004-5-2-209 · Cited by 153
Damme, P. V., Bosch, L. V. D., Houtte, E. V., Callewaert, G., & Robberecht, W. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.3.1279 · Cited by 145
Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?
Turner, M. R., & Kiernan, M. C. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.636050 · Cited by 144
The Puzzling Case of Hyperexcitability in Amyotrophic Lateral Sclerosis
Bae, J. S., Simon, N. G., Menon, P., Vucic, S., & Kiernan, M. C. (2013) · Journal of Clinical Neurology · doi:10.3988/jcn.2013.9.2.65 · Cited by 143
GluA2-lacking, calcium-permeable AMPA receptors--inducers of plasticity?
Man, H.-Y. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.01.001 · Cited by 142
Yang, D., Abdallah, A., Li, Z., Lu, Y., Almeida, S., & Gao, F. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1448-6 · Cited by 137
Henstridge, C. M., Sideris, D. I., Carroll, E., Rotariu, S., Salomonsson, S. E., Tzioras, M., McKenzie, C.-A., Smith, C., Arnim, C. A. F. V., Ludolph, A. C., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1797-4 · Cited by 136
Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity
Woo, J. A., Liu, T., Trotter, C., Fang, C. C., Narvaez, E. D., LePochat, P., Maslar, D., Bukhari, A., Zhao, X., Deonarine, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15558 · Cited by 135
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
Pascuzzi, R. M., Shefner, J. M., Chappell, A. S., Bjerke, J. S., Tamura, R., Chaudhry, V., Clawson, L., Haas, L., & Rothstein, J. D. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903307805 · Cited by 134
Madill, M., McDonagh, K., Ma, J., Vajda, A., McLoughlin, P., O’Brien, T., Hardiman, O., & Shen, S. (2017) · Molecular Brain · doi:10.1186/s13041-017-0300-4 · Cited by 134
Decker, J. M., Krüger, L., Sydow, A., Dennissen, F. J. A., Šišková, Z., Mandelkow�, E., & Mandelkow, E. (2016) · EMBO Reports · doi:10.15252/embr.201541439 · Cited by 130
de Carvalho, M. A., Pinto, S., Costa, J. N., Evangelista, T., Ohana, B., & Pinto, A. C. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.498521 · Cited by 125
Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease
Gaisler‐Salomon, I., Kravitz, E., Feiler, Y., Safran, M., Biegon, A. R., Amariglio, N., & Rechavi, G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.018 · Cited by 121
TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2
Aizawa, H., Sawada, J., Hideyama, T., Yamashita, T., Katayama, T., Hasebe, N., Kimura, T., Yahara, O., & Kwak, S. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0678-x · Cited by 119
Viral-Induced Spinal Motor Neuron Death Is Non-Cell-Autonomous and Involves Glutamate Excitotoxicity
Darman, J., Backovic, S., Dike, S., Maragakis, N. J., Krishnan, C., Rothstein, J. D., Irani, D. N., & Kerr, D. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2002-04.2004 · Cited by 115
Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD
Khosravi, B., Hartmann, H., May, S., Möhl, C., Ederle, H., Michaelsen, M., Schludi, M. H., Dormann, D., & Edbauer, D. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw432 · Cited by 113
Neuronal and glial cell biology Editorial overview
Kelly, R. B., & Reichardt, L. F. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90001-9 · Cited by 111
Belly, A., Moreau-Gachelin, F., Sadoul, R., & Goldberg, Y. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.071 · Cited by 107
Gendron, T. F., van Blitterswijk, M., Bieniek, K. F., Daughrity, L. M., Jiang, J., Rush, B. K., Pedraza, O., Lucas, J. A., Murray, M. E., Desaro, P., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1474-4 · Cited by 106
Berry, J. D., Shefner, J. M., CONWIT, R. A., Schoenfeld, D., Keroack, M. D., Felsenstein, D., Krivickas, L. S., David, W. S., Vriesendorp, F. J., Pestronk, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061177 · Cited by 106
Maharjan, N., Künzli, C., Buthey, K., & Saxena, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9850-1 · Cited by 105
Coyne, A. N., Lorenzini, I., Chou, C., Torvund, M., Rogers, R. S., Starr, A., Zaepfel, B. L., Levy, J., Johannesmeyer, J., Schwartz, J. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.028 · Cited by 105
Self-citationYokoi, S., Udagawa, T., Fujioka, Y., Honda, D., Okado, H., Watanabe, H., Katsuno, M., Ishigaki, S., & Sobue, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.100 · Cited by 104
Early and Persistent Abnormal Decoding by Glial Cells at the Neuromuscular Junction in an ALS Model
Arbour, D., Tremblay, E., Martineau, É., Julien, J., & Robitaille, R. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1379-14.2015 · Cited by 101
Neuronal and glial cell biology
Barres, B. A., & Barde, Y. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00134-3 · Cited by 101
Melcher, T., Maas, S., Higuchi, M., Keller, W., & Seeburg, P. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8566 · Cited by 99
Kim, J., Hughes, E. G., Shetty, A. S., Arlotta, P., Goff, L. A., Bergles, D. E., & Brown, S. P. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0811-17.2017 · Cited by 99
Burguete, A. S., Almeida, S., Gao, F., Kalb, R. G., Akins, M. R., & Bonini, N. M. (2015) · eLife · doi:10.7554/elife.08881 · Cited by 98
The function of RNA-binding proteins at the synapse: implications for neurodegeneration
Sephton, C. F., & Yu, G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1943-x · Cited by 97
Rojas, F., González, D., Cortés, N., Ampuero, E., Hernández, D. E., Fritz, E., Abarzúa, S., Martinez, A. N., Elorza, Á. A., Alvarez, A. R., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00203 · Cited by 97
Excitatory amino acids in amyotrophic lateral sclerosis: An update
Rothstein, J. D., Kuncl, R. W., Chaudhry, V., Clawson, L., Cornblath, D. R., Coyle, J. T., & Drachman, D. B. (1991) · Annals of Neurology · doi:10.1002/ana.410300223 · Cited by 96
Lai, C., Xie, C., McCormack, S. G., Chiang, H., Michalak, M. K., Lin, X. Z., Chandran, J. S., Shim, H., Shimoji, M., Cookson, M., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2084-06.2006 · Cited by 93
Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation
Coyne, A. N., Yamada, S. B., Siddegowda, B. B., Estes, P. S., Zaepfel, B. L., Johannesmeyer, J., Lockwood, D. B., Pham, L. T., Hart, M. P., Cassel, J. A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv389 · Cited by 92
Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model
Wang, R., & Zhang, D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04431.x · Cited by 91
Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia
West, R. J. H., Lu, Y., Marie, B., Gao, F., & Sweeney, S. T. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201404066 · Cited by 89
Cortical Function in Asymptomatic Carriers and Patients WithC9orf72Amyotrophic Lateral Sclerosis
Geevasinga, N., Menon, P., Nicholson, G. A., Ng, K., Howells, J., Kril, J. J., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1872 · Cited by 88
Yamashita, T., & Kwak, S. (2013) · Brain Research · doi:10.1016/j.brainres.2013.12.011 · Cited by 84
Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis
Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612823666170622095802 · Cited by 84
Warmus, B. A., Sekar, D. R., McCutchen, E., Schellenberg, G. D., Roberts, R. C., McMahon, L. L., & Roberson, E. D. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3418-14.2014 · Cited by 82
Washburn, M. C., Kakaradov, B., Sundararaman, B., Wheeler, E. C., Hoon, S. S., Yeo, G. W.-M., & Hundley, H. A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.011 · Cited by 81
Do‐Ha, D., Buskila, Y., & Ooi, L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0392-y · Cited by 81
Arbour, D., Velde, C. V., & Robitaille, R. (2016) · The Journal of Physiology · doi:10.1113/jp270213 · Cited by 79
Ryberg, H., Askmark, H., & Persson, L. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00111.x · Cited by 78
Perry, S., Han, Y., Das, A., & Dickman, D. K. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx304 · Cited by 78
Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2
Gorrie, G., Fecto, F., Radzicki, D., Weiss, C., Shi, Y., Dong, H., Zhai, H., Fu, R., Liu, E., Li, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405741111 · Cited by 77
Shahidullah, M., Marchand, S. J. L., Hong, F., Zhang, J., Pandey, U. B., Dalva, M. B., Pasinelli, P., & Levitan, I. B. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3396-13.2013 · Cited by 76
Gong, Y., & Lippa, C. F. (2010) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317510382893 · Cited by 76
Fogarty, M. J., Mu, E. W. H., Noakes, P. G., Lavidis, N. A., & Bellingham, M. C. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0347-y · Cited by 76
Comley, L. H., Allodi, I., Nichterwitz, S., Nizzardo, M., Simoné, C., Corti, S. P., & Hedlund, E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.013 · Cited by 75
The GluR2 hypothesis: Ca(++)-permeable AMPA receptors in delayed neurodegeneration.
Bennett, M. V. L., Pellegrini-Giampietro, D. E., Gorter, J. A., Aronica, E., Connor, J. A., & Zukin, R. S. (1996) · PubMed · Cited by 74
Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis
Casas, C., Herrando‐Grabulosa, M., Manzano, R., Mancuso, R., Osta, R., & Navarro, X. (2013) · Brain and Behavior · doi:10.1002/brb3.104 · Cited by 73
Kawahara, Y., Ito, K., Sun, H., Kanazawa, I., & Kwak, S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02718.x · Cited by 73
Tremblay, E., Martineau, É., & Robitaille, R. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3090-16.2017 · Cited by 73
Role of the N-methyl-d-aspartate receptors complex in amyotrophic lateral sclerosis
Spalloni, A., Nutini, M., & Longone, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.013 · Cited by 72
Akamatsu, M., Yamashita, T., Hirose, N., Teramoto, S., & Kwak, S. (2016) · Scientific Reports · doi:10.1038/srep28649 · Cited by 72
ALS and FTD: an epigenetic perspective
Belzil, V., Katzman, R. B., & Petrucelli, L. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1587-4 · Cited by 71
Morphological changes of glutamatergic synapses in animal models of Parkinson’s disease
Villalba, R. M., Mathai, A., & Smith, Y. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00117 · Cited by 70
Genetic Overlap between Apparently Sporadic Motor Neuron Diseases
van Blitterswijk, M., Vlam, L., van Es, M. A., van der Pol, W. L., Hennekam, E. A. M., Dooijes, D., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Veldink, J. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048983 · Cited by 69
Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity
Daigle, J. G., Krishnamurthy, K., Ramesh, N., Casci, I., Monaghan, J., McAvoy, K. J., Godfrey, E. W., Daniel, D. C., Johnson, E. M., Monahan, Z. T., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1530-0 · Cited by 69
Glial Cells and Integrity of the Nervous System
von Bernhardi, R., Eugenín-von Bernhardi, J., Flores, B., & Eugenín León, J. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-40764-7_1 · Cited by 67
The UPR and synaptic dysfunction in neurodegeneration
Freeman, O. J., & Mallucci, G. R. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.029 · Cited by 66
Lasiene, J., Komine, O., Fujimori-Tonou, N., Powers, B. E., Endo, F., Watanabe, S., Jin, S., Ravits, J., Horner, P. J., Misawa, H., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0286-7 · Cited by 62
Motor Areas Show Altered Dendritic Structure in an Amyotrophic Lateral Sclerosis Mouse Model
Fogarty, M. J., Mu, E. W. H., Lavidis, N. A., Noakes, P. G., & Bellingham, M. C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00609 · Cited by 62
Paul, P., & de Belleroche, J. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00010 · Cited by 59
Translational control at the synapse: role of RNA regulators
Iacoangeli, A., & Tiedge, H. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.11.001 · Cited by 57
Axonal Excitability in Amyotrophic Lateral Sclerosis
Park, S. B., Kiernan, M. C., & Vucic, S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0492-9 · Cited by 57
Larroquette, F., Seto, L., Gaub, P., Kamal, B., WALLIS, D. E., Larivière, R., Vallée, J., Robitaille, R., & Tsuda, H. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv360 · Cited by 55
Ruegsegger, C., Maharjan, N., Goswami, A., de L’Etang, A. F., Weis, J., Troost, D., Heller, M., Gut, H., & Saxena, S. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1510-4 · Cited by 55
Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis
Iwai, Y., Shibuya, K., Misawa, S., Sekiguchi, Y., Watanabe, K., Amino, H., & Kuwabara, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158596 · Cited by 53
Memory, plasticity and sleep - A role for calcium permeable AMPA receptors?
Shepherd, J. D. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00049 · Cited by 49
Rzhepetskyy, Y., Łaźniewska, J., Blesneac, I., Pamphlett, R., & Weiss, N. (2016) · Channels · doi:10.1080/19336950.2016.1204497 · Cited by 49
Shibuya, K., Misawa, S., Kimura, H., Noto, Y., Sato, Y., Sekiguchi, Y., Iwai, Y., Mitsuma, S., Beppu, M., Watanabe, K., et al. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1038277 · Cited by 45
Analysis of AMPA receptor subunit mRNA expression in control and ALS spinal cord
Virgo, L., Samarasinghe, S., & de Belleroche, J. (1996) · Neuroreport · doi:10.1097/00001756-199611040-00021 · Cited by 45
Filipchuk, A., & Durand, J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.046 · Cited by 45
Joo, I.-S., Hwang, D.-H., Seok, J. I., Shin, S.-K., & Kim, S. U. (2007) · Journal of Clinical Neurology · doi:10.3988/jcn.2007.3.4.181 · Cited by 45
Axonal Ion Channel Dysfunction inC9orf72Familial Amyotrophic Lateral Sclerosis
Geevasinga, N., Menon, P., Howells, J., Nicholson, G. A., Kiernan, M. C., & Vucic, S. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2940 · Cited by 44
Chronological requirements of TDP-43 function in synaptic organization and locomotive control
Romano, G., Klima, R., Buratti, E., Verstreken, P., Baralle, F. E., & Feiguin, F. M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.007 · Cited by 43
Chang, Q., & Martin, L. J. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.009 · Cited by 43
Mahajan, S. S., Thai, K. H., Chen, K., & Ziff, E. B. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.027 · Cited by 41
Milan, L., Courtand, G., Cardoit, L., Masmejean, F., Barrière, G., Cazalets, J., Garret, M., & Bertrand, S. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135525 · Cited by 39
Spalloni, A., Origlia, N., Sgobio, C., Trabalza, A., Nutini, M., Berretta, N., Bernardi, G., Domenici, L., Ammassari‐Teule, M., & Longone, P. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhq152 · Cited by 39
Aizawa, H., Hideyama, T., Yamashita, T., Kimura, T., Suzuki, N., Aoki, M., & Kwak, S. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.12.039 · Cited by 39
Herranz-Martín, S., Chandran, J. S., Lewis, K. E. A., Mulcahy, P. J., Higginbottom, A., Walker, C., y Valenzuela, I. M.-P., Jones, R. A., Coldicott, I., Iannitti, T., et al. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029892 · Cited by 39
Sgobio, C., Trabalza, A., Spalloni, A., Zona, C., Carunchio, I., Longone, P., & Ammassari‐Teule, M. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00367.x · Cited by 38
Paul, P., & de Belleroche, J. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.12.040 · Cited by 37
Vernay, A., Therreau, L., Blot, B., Risson, V., Dirrig‐Grosch, S., Waegaert, R., Lequeu, T., Sellal, F., Schaeffer, L., Sadoul, R., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw182 · Cited by 35
Cortical hyperexcitability in patients withC9ORF72mutations: Relationship to phenotype
Schanz, O., Bageac, D. V., Braun, L. E., Traynor, B. J., Lehky, T., & Floeter, M. K. (2016) · Muscle & Nerve · doi:10.1002/mus.25047 · Cited by 34
Hideyama, T., Teramoto, S., Hachiga, K., Yamashita, T., & Kwak, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043469 · Cited by 29
PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons
Yang, D., Wang, X.-L., Ismail, A., Ashman, C. J., Valori, C. F., Wang, G., Gao, S., Higginbottom, A., Ince, P. G., Azzouz, M., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.55 · Cited by 25
Shiihashi, G., Ito, D., Arai, I., Kobayashi, Y., Hayashi, K., Otsuka, S., Nakajima, K., Yuzaki, M., Itohara, S., & Suzuki, N. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.005 · Cited by 25
Kiernan, M. C. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.039 · Cited by 23
Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers
Vucic, S., Winhammar, J. M., Rowe, D. B., & Kiernan, M. C. (2010) · Clinical Neurophysiology · doi:10.1016/j.clinph.2010.02.164 · Cited by 23
Flagged first, then by citations
2 of the 211 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Geevasinga, 2015, Cortical function in asymptomatic carriers and patients With C9orf72 amyotrophic lateral sclerosis, JAMA Neurol., 1
Cited by
Sorted by citations
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
C9ORF72: What It Is, What It Does, and Why It Matters
Smeyers, J., Banchi, E.-G., & Latouche, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661447 · Cited by 198
Repeat‐associated non‐AUG translation in C9orf72‐ALS/FTD is driven by neuronal excitation and stress
Westergard, T., McAvoy, K., Russell, K. A., Wen, X., Pang, Y., Verdone, B. M., Pasinelli, P., Trotti, D., & Haeusler, A. R. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809423 · Cited by 126
Liu, W., Venugopal, S., Majid, S., Ahn, I. S., Diamante, G., Hong, J. S., Yang, X., & Chandler, S. H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104877 · Cited by 88
Abnormal Mitochondrial Quality Control in Neurodegenerative Diseases
Yan, X., Wang, B., Hu, Y., Wang, S., & Zhang, X. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00138 · Cited by 74
Metadata
- Authors
- Starr, A., & Sattler, R.
- Affiliations
- Barrow Neurological Institute (US)
- Corresponding author
- Sattler, Rita
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 1693
- Issue
- Pt A
- Pages
- 98-108
- ISSN
- 0006-8993 (ISSN-L)
- PMC
- PMC5997509
- OpenAlex
- W2790884408
- Cited by
- 78
- References
- 211
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 9 · 2023: 7 · 2022: 21 · 2021: 15 · 2020: 10 · 2019: 5 · 2018: 3
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- Fogarty International Center
- National Institute of Neurological Disorders and Stroke (R01NS085207)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- C9orf72, amyotrophic lateral sclerosis, frontotemporal dementia, synaptic dysfunction, neuronal excitability, excitotoxicity, RNA-binding proteins, hexanucleotide repeat expansion, dipeptide repeat proteins, repeat-associated non-ATG translation, RNA foci, neuromuscular junction, synaptogenesis, motor neurons, therapeutic target
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Animals, Humans, Motor Neurons, Mutation, RNA, Synapses, RNA-Binding Proteins, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review